Nav button
About Us
Our Company
Leadership
Board of Directors
Founders
Scientific Advisory Board
Contact Us
Science
SLT
x
PLatform
Publications
Pipeline
Patients & Caregivers
Overview
Diabetes
Lysosomal Diseases
Investors/Media
Investor/Media Home
News & Events
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters
Leadership
Board of Directors
Committee Composition
Investor Relations
Investor FAQ
Email Alerts
Inside Sigilon
Our Culture
Job Opportunities
Media Coverage
Back to Media Coverage
Tunable Cell Therapies
Sigilon’s allogeneic cell therapy implants offer long-term but flexible dosing.
